• 1
    Diabetes Control and Complications Trial Research Group. The effect of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977986.DOI: 10.1056/NEJM199309303291401
  • 2
    Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271286.
  • 3
    Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561568.
  • 4
    Diabetes Control and Complications Trial Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. The Epidemiology of Diabetes Interventions and Complications (EDIC) Study. JAMA 2003; 290: 21592167.DOI: 10.1001/jama.290.16.2159
  • 5
    Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Opthalmol 1998; 116: 874886.
  • 6
    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 2002; 287: 25632569.DOI: 10.1001/jama.287.19.2563
  • 7
    Gruessner Angelika C, Sutherland David ER. Pancreas transplant outcomes for United States and non-US cases as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry as of October, 2002. In: CeckaJM, TerasakiPI, eds. Clinical Transplants 2002. Los Angeles , CA : UCLA Immunogenetics Center , 2003: 4178.
  • 8
    International Islet Transplant Registry Newsletter. BrendelMD, SchultzAO, HeringBJ, BretzelRG, eds. Available at:
  • 9
    Robertson Paul R. Medical progress: Islet transplantation as a treatment for diabetes—A work in progress. N Eng J Med 2004; 350: 694705.DOI: 10.1056/NEJMra032425
  • 10
    Fioretto P, Steffes MW, Sutherland DE et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Eng J Med 1998; 339: 6975.DOI: 10.1056/NEJM199807093390202
  • 11
    Venstrom JM, McBride MA, Rother KI et al. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290: 28172833.DOI: 10.1001/jama.290.21.2817
  • 12
    Gruessner RWG, Sutherland DER, Najarian JS et al. Solitary pancreas transplantation for nonuremic patients with labile insulin-dependent diabetes mellitus. Transplantation 1997; 64: 15721577.DOI: 10.1097/00007890-199712150-00011
  • 13
    Gruessner AC, Sutherland DER, Dunn DL et al. Pancreas after kidney transplants in posturemic patients with type 1 diabetes mellitus. J Am Soc Nephrol 2001; 12: 24902499.
  • 14
    Sutherland DER, Gruessner RWG, Dunn DL et al. Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463501.DOI: 10.1097/00000658-200104000-00003
  • 15
    Meier-Kriesche H-U, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 12911295.DOI: 10.1097/01.TP.0000061602.03327.E2
  • 16
    Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Eng J Med 1999; 341: 17251730.DOI: 10.1056/NEJM199912023412303
  • 17
    Mauger EA, Wolfe RA, Port FK. Transient effects in the Cox proportional hazards regression model. Stat Med 1995; 14: 15531565.
  • 18
    Port FK, Wolfe RA, Mauger EA et al. Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 1993; 270: 13391343.DOI: 10.1001/jama.270.11.1339
  • 19
    Ojo AO, Wolfe RA, Agodoa LY, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: Multivariate analyses from the United States renal data system. Transplantation 1998; 66: 16511659.DOI: 10.1097/00007890-199812270-00014
  • 20
    Ojo AO, Meier-Kriesche H-U, Hanson JA et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 8290.DOI: 10.1097/00007890-200101150-00014
  • 21
    Bunnapradist S, Cho YW, Cecka JM et al. Kidney allograft and patient survival in type 1 diabetic recipients of cadaveric kidney alone versus simultaneous pancreas/kidney transplants: A multivariate analysis of the UNOS database. J Am Soc Nephrol 2003; 14: 208213.
  • 22
    Reddy KS, Stablein D, Taranto S et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 2003; 41: 464470.DOI: 10.1053/ajkd.2003.50057
  • 23
    Nishimura R, LaPorte RE, Dorman JS et al. Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 2001; 24: 823827.
  • 24
    Gross CR, Limwattananon C, Matthees B et al. Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation 2000; 70: 17361746.DOI: 10.1097/00007890-200012270-00013
  • 25
    Navarro X, Kennedy WR, Aeppli DA, Sutherland DER. Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve 1996; 19: 10091016.DOI: 10.1002/(SICI)1097-4598(199608)19:8<1009::AID-MUS9>3.0.CO;2-4